Rapid Nutrition PLC – Strategic Outlook and Near-Term Execution Update

Well-capitalised HealthTech group enters delivery phase across platform expansion, selective acquisitions and science-led product development

LONDON, Feb. 18, 2026 (GLOBE NEWSWIRE) -- Rapid Nutrition PLC, a HealthTech company trading on Euronext Growth Paris (ALRPD), provides a strategic outlook update as the Company enters a focused execution phase across its core growth initiatives.

Rapid Nutrition is transitioning from a premium nutraceuticals business to a personalised, platform-led HealthTech operating model focused on evidence-based nutrition and immune wellness. Supported by an established operating portfolio, subscription-led engagement and disciplined capital allocation, the Company is further anchored by recent long-term institutional funding and is well-capitalised to execute.

The Board believes the Company has reached an inflection point, moving from strategy to delivery.

The Company operates a portfolio of science-led wellness brands that generate revenue today and underpin its platform strategy. SystemLS® delivers evidence-based nutrition products supported by personalised assessment frameworks. Azurene™ focuses on immune and preventive wellness through differentiated formulations, including blends originally developed as patented combinations of herbs, with ongoing refinement and expansion across APAC.

In addition, Rapid Nutrition is selectively expanding its product portfolio through licensed, evidence-based ingredients in high-demand functional nutrition categories.

Rapid Nutrition operates a diversified, multi-channel business model across direct-to-consumer, subscription, wholesale, practitioner and strategic partnership channels. As part of its platform-led growth strategy, the Company has entered discussions with a target group aligned with its strategic criteria and is confident in its ability to progress the opportunity in the near term, subject to customary diligence and approvals.

Near-Term Execution Priorities

• Expansion of personalised assessment frameworks
• Acceleration of product-led growth in priority evidence-based categories
• Optimisation of direct-to-consumer and marketplace channels
• Targeted international expansion across APAC and the United States
• Progression of selective expansion and consolidation initiatives
  

The Board remains confident in the Company’s growth trajectory and expects the upcoming financial period to reflect meaningful progress across its strategic priorities.

About Rapid Nutrition

Rapid Nutrition is a global HealthTech company dedicated to advancing wellness through evidence-based, personalized nutrition solutions. Leveraging advanced technologies, AI, and scientific research, the company is committed to optimizing nutrition, improving health outcomes, and fostering sustainable, healthier lifestyles worldwide.

Investor Relations Contact:
ir@rnplc.com

Media Contact:
Fairfaxpartners: Fair@ir.fairfax.partners

Disclaimer
This announcement contains forward-looking statements, including statements regarding the Company’s expectations, intentions, plans, beliefs or forecasts. Forward-looking statements involve known and unknown risks, uncertainties and other factors which may cause actual results, performance or developments to differ materially from those expressed or implied by such statements. These forward-looking statements are based on assumptions and assessments made by the Company in light of its experience and perception of historical trends, current conditions and expected future developments. Forward-looking statements speak only as at the date of this announcement.

Except as required by applicable law or regulation, Rapid Nutrition PLC undertakes no obligation to publicly update or revise any forward-looking statements, whether as a result of new information, future events or otherwise. Forward-looking statements are provided for illustrative purposes only and are not guarantees of future performance.

This announcement is for information purposes only and does not constitute, or form part of, any offer or invitation to sell or issue, or any solicitation of any offer to purchase or subscribe for, any securities of Rapid Nutrition PLC in any jurisdiction. This announcement does not constitute a prospectus, offering memorandum or admission document for the purposes of the UK prospectus regime, Regulation (EU) 2017/1129 (the “Prospectus Regulation”), the U.S. Securities Act of 1933 (as amended), or the rules of any securities exchange or trading venue.

The distribution of this announcement may be restricted by law in certain jurisdictions. Persons into whose possession this announcement comes are required to inform themselves about, and to observe, any such restrictions. Any failure to comply with such restrictions may constitute a violation of applicable securities laws.

Rapid Nutrition PLC has engaged Fairfax Partners Inc., based in Vancouver, British Columbia, to provide investor relations and communications services. The service agreement has an initial term of three months commencing January 1, 2026. In consideration for the services, the Company will pay Fairfax Partners a monthly cash fee of €50,000 plus applicable taxes. Fairfax Partners is an independent third-party service provider. Neither Fairfax Partners nor its principals